Drugs / OPC-249
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00504426 Comparator | Jul 2007 → Jul 2008 | osteoporosis | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC-249 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00504426 ↗ |
| Route | Inhaled | “Powder Inhalation” NCT00504426 ↗ |